AlzeCure Pharma has announced that the European Medicines Agency has granted orphan drug status to ACD440, its clinical‑stage ...

ViiV Healthcare has announced new 96‑week findings from a sub‑group analysis of the PASO DOBLE study, showing that adults ...

Johnson & Johnson has reported new long‑term results from the QUASAR long‑term extension study, showing that Tremfya (guselkumab) sustained clinical, endoscopic and histologic outcomes through week ...

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as ...

Lario Therapeutics has secured $2.4 million in new grant funding from The Michael J Fox Foundation for Parkinson’s Research ...

Mikrobiomik has become the first organisation in Spain to receive authorisation to prepare and process faecal microbiota for treating Clostridioides difficile infection, following approval of its oral ...

GSK has secured European Commission approval for Exdensur (depemokimab) to treat severe asthma with type 2 inflammation and ...

Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...

Enhanced Genomics, the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, has announced that Katerina ...

Dr Michael Chen, CEO and co‑founder of Nuclera, said: “Scientists are under pressure to progress increasingly complex membrane protein programs faster. By partnering with leadXpro, we can pair ...

Muhunthan Thillai MD, co-founder and CEO, Qureight, commented: “Rebecca’s experience, expertise and people-centric leadership ...

Lundbeck A/S has announced encouraging new data from the intravenous part of its phase 2b PROCEED trial, showing that ...